Physician profile
Clark Laprelle
NPI 1306396338
$581.67
in general payments reported to CMS, 2019-2025
9 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $57.01 · 2023: $274 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $196.22 | 2025 | Senza |
| Stryker Corporation | $149.90 | 2023 | Gamma |
| Lilly USA, LLC | $64.41 | 2022-2023 | Emgality, Reyvow |
| Neurocrine Biosciences, INC. | $44.84 | 2023 | Ingrezza, Ongentys |
| Avion Pharmaceuticals | $37.07 | 2022-2023 | Dhivy |
| Vertex Pharmaceuticals Incorporated | $30.86 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $23.19 | 2025 | Iovera, Zilretta, Exparel |
| Argenx US, INC. | $20.61 | 2023 | Vyvgart Hytrulo |
| Medtronic, INC. | $14.57 | 2023 | Aquamantys(Tm) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clark Laprelle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.